UNSPSC 51422417: Hydrocortisone butyrate

This classification denotes a therapeutic glucocorticoid with the molecular formula C25H36O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 05RMF7YPWN, chemically known as 11beta,17alpha,21-trihydroxypregn-4-ene-3,20-dione but generally known as hydrocortisone butyrate, which bears US NIH Compound Identifier 5754. European Medicines Agency schedules Hydrocortisone butyrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02563MIG.

UNSPSC 51422417 Hydrocortisone butyrate is a Commodity code for a specific pharmaceutical product, but the recent state and local opportunities posted under this code show no alignment with hydrocortisone butyrate procurement itself. The most recent activity tagged to this code includes Seminole County, Florida's IFB for naloxone and drug deactivation systems (posted June 30, 2026, response due July 26, 2023) and the Texas Health and Human Services Commission's RFI on direct-to-manufacturer prescription programs (posted April 3, 2026). Neither solicitation concerns hydrocortisone butyrate or topical corticosteroid products. The code shows minimal relevant recent activity; issuers appear to be health and human services agencies and county health departments, but the mismatch between the nominal scope and the actual opportunities suggests this code either receives sporadic use or is being misapplied in these instances.

The geographic spread of recent postings spans Florida and Texas, though both opportunities address broader pharmaceutical supply, naloxone distribution, or pharmacy benefit management rather than the specific steroid pharmaceutical named in the code. Seminole County's IFB seeks 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries with a two-year initial term and one-year renewal option; responses were due by July 26, 2023. The Texas HHS Commission's RFI is exploratory market intelligence on direct-to-manufacturer prescription contracting models and does not commit to specific volumes or budgets. If your firm supplies hydrocortisone butyrate to state and local health authorities, this code presents limited current opportunity visibility; monitor for future RFPs from state Medicaid agencies or health departments that may use the code more consistently.